美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA213049"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
72205-045-01 72205-045 HUMAN PRESCRIPTION DRUG Thiotepa Thiotepa INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRACAVITARY; INTRAVENOUS; INTRAVESICAL 20200201 N/A ANDA ANDA213049 Novadoz Pharmaceuticals LLC THIOTEPA 15 mg/1 1 VIAL, GLASS in 1 BOX (72205-045-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS
72205-046-01 72205-046 HUMAN PRESCRIPTION DRUG Thiotepa Thiotepa INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRACAVITARY; INTRAVENOUS; INTRAVESICAL 20200201 N/A ANDA ANDA213049 Novadoz Pharmaceuticals LLC THIOTEPA 100 mg/1 1 VIAL, GLASS in 1 BOX (72205-046-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS
69539-123-01 69539-123 HUMAN PRESCRIPTION DRUG Thiotepa Thiotepa INJECTION, POWDER, FOR SOLUTION INTRACAVITARY; INTRAVENOUS; INTRAVESICAL 20200304 N/A ANDA ANDA213049 MSN LABORATORIES PRIVATE LIMITED THIOTEPA 15 mg/1 1 VIAL, GLASS in 1 BOX (69539-123-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS
69539-124-01 69539-124 HUMAN PRESCRIPTION DRUG Thiotepa Thiotepa INJECTION, POWDER, FOR SOLUTION INTRACAVITARY; INTRAVENOUS; INTRAVESICAL 20200304 N/A ANDA ANDA213049 MSN LABORATORIES PRIVATE LIMITED THIOTEPA 100 mg/1 1 VIAL, GLASS in 1 BOX (69539-124-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase